Lung cancer drug trial halted: new contender vs keytruda
Disease control
Terminated
This study tested a new drug called BAT3306 against the standard treatment Keytruda, both given with chemotherapy, for people with stage IV non-squamous non-small cell lung cancer. The goal was to see if BAT3306 works as well and is as safe as Keytruda. The trial was terminated e…
Phase: PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC